Blood cells
Blood cells

Paroxysmal nocturnal hemoglobinuria (PNH)

Definition:
A rare, acquired disorder of red blood cells in which an abnormal cell surface molecule leads to premature destruction (hemolysis) of the cells. This destruction is intermittent (paroxysmal).

Alternative Names:
PNH

Causes, incidence, and risk factors:
The exact cause is unknown. It is thought to be a disorder of the stem cell (the precursor of blood cells) in which a sensitivity to complement (a substance produced by the immune system) occurs in the cell membrane. The disease can affect people of any age. Red blood cell, white blood cell and platelet counts may be low. Urine may be intermittently red or brown, signifying the breakdown of red blood cells with release of hemoglobin into the circulation and then the urine. Blood clots may form in some people. The disease may arise in relation to aplastic anemia, and may progress to acute myelogenous leukemia. Risk factors, except for prior aplastic anemia, are not known.
Symptoms:
Signs and tests:
This disease may also alter the results of the following tests:
Treatment:
Steroids may be effective in suppressing hemolysis. Blood transfusions may be required. Anticoagulation therapy may also be required to prevent clot formation. Antithymocyte globulin (ATG), a therapy derived from horse serum, may help restore normal blood cell production. Bone marrow transplantation, when successful, can cure this disease.
Expectations (prognosis):
The outcome is variable, with most people surviving approximately 10 years following diagnosis. In rare cases, the abnormal cells may decrease over time. Death can be caused by complications of blood clot formation (thrombosis).
Complications:
Calling your health care provider:

Call your health care provider if you find blood in your urine, if symptoms worsen or do not improve with treatment or if new symptoms develop.

Prevention:
There is no known way to prevent this disorder.

Review Date: 10/10/2001
Reviewed By: Rebecca Elstrom, M.D., Division of Hematology-Oncology, University of Pennsylvania Medical Center, Philadelphia, PA. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.